GMED · Globus Medical Inc
Snapshot
50 fields · last close| Market Cap | $10.25B |
| P/E | 19.12 |
| Float | 112.2M |
| Beta | 0.97 |
| Volatility | 24.2% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 76.1 |
| Price | 75.54 |
| Change | −1.02% |
| Prev Close | 76.32 |
| Open | 76.70 |
| Day Low | 74.98 |
| Day High | 76.71 |
| Avg Vol | 2 |
| Avg $ Vol | $116.7M |
| 52W High | 101.40 |
| 52W Low | 56.50 |
| 52W Pos | 42.4% |
| From High | −25.50% |
| From Low | +33.70% |
| Max DD 1Y | — |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | — |
| SMA 50 | — |
| SMA 200 | — |
| RSI (14) | — |
| Vol 30D | — |
| Vol 90D | — |
| 1Y Range | 56–101 |
| Daily bars | — |
| Perf Week | — |
| Perf Month | — |
| Perf Quarter | — |
| Perf Half Y | — |
| Perf Year | — |
| Perf YTD | — |
| Prev Day | −1.02% |
| Clavix | B |
| Debt / Eq | 0.00 |
| Curr Ratio | 4.26 |
| Int Cover | 45.1× |
| FCF Margin | 20.0% |
| Rev Growth | +16.6% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 28 / 49 |
Clavix risk grade
regraded every trading dayGMED grades B, 76.1 of 100. Steadiest on Macro Resilience (67), most exposed on Sector Resilience (56, mixed). 1 of the 4 weighted dimensions sit above the Health Care median. Ranks 28 of 49 in Health Care by Clavix score.
How rough the ride is
| GMED | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.97 | 0.85 |
| Volatilityannualized | 24.2% | 21.3% |
| Max drawdown, past yearworst peak-to-trough fall | — | — |
| Typical daily movemedian absolute daily change | — | — |
| Days beyond ±3%of the last 0 sessions | — | — |
Market sensitivity
| GMED | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.97 | 0.85 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| GMED | |
|---|---|
| 1 week | — |
| 1 month | — |
| Year to date | — |
| 1 year | — |
Context for the rank, not itself a risk measure.
No scored coverage for GMED in the recent pool.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| GMED | |
|---|---|
| Revenue growthyear over year | +16.6% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| ALGN | Align Technology Inc | B | $10.20B | 24.43 | 1.74 | Compare |
| COO | Cooper Companies Inc | B- | $10.38B | 18.55 | 0.83 | Compare |
| UHS | Universal Health Services Inc | A- | $10.55B | 6.87 | 1.12 | Compare |
| GKOS | Glaukos Corp | B | $9.76B | — | 0.73 | Compare |
| MOH | Molina Healthcare Inc | B | $10.94B | 23.74 | 0.74 | Compare |
| PODD | Insulet Corp | B- | $9.58B | 26.01 | 1.09 | Compare |
| HSIC | Henry Schein Inc | A- | $9.48B | 23.32 | 0.86 | Compare |
| DVA | DaVita Inc | B | $11.62B | 13.76 | 0.88 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.